Pressreleaser

• 2020-09-25

  NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience

  NeoDynamics AB (publ), (Spotlight Stock Market: NEOD), today announced that the company is ready to launch the new pulse biopsy system NeoNavia. The biopsy system has been very well received at recent international Senology congresses in Vienna and Lucerne, and for the first-time physicians have gained hands-on experience of the final product. Weiterlesen

• 2020-08-21

  NeoDynamics AB (publ) Half year report 2020

  NeoNavia ready for market Weiterlesen

• 2020-07-06

  NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer

  Stockholm July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), today announced that the Company has initiated a collaboration with leading breast cancer clinics in  Germany, which will act as reference centres supporting the introduction of the new pulse biopsy system NeoNavia, paving the way for a successful market introduction in Europe. Weiterlesen

• 2020-07-06

  NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

  STOCKHOLM - July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), announces that the Company restarts patient recruitment to the UK COMPULSE Study following a temporary pause imposed by the COVID-19 pandemic. Weiterlesen

• 2020-05-26

  NeoDynamics AB (publ) First Quarter 2020

  Somewhat higher development cost, but mainly in line Weiterlesen